相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of Natural and Added Dietary Phosphorus Burden in Kidney Disease
Adamasco Cupisti et al.
SEMINARS IN NEPHROLOGY (2013)
Phosphate Binder Use and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status
Antonio Alberto Lopes et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Pill burden in HIV infection: 20 years of experience
Hartmut B. Krentz et al.
ANTIVIRAL THERAPY (2012)
Assessment of Pharmacodynamic Equivalence and Tolerability of Lanthanum Carbonate Oral Powder and Tablet Formulations: A Single-Center, Randomized, Open-Label, 2-Period Crossover Study in Healthy Subjects
David Pierce et al.
CLINICAL THERAPEUTICS (2012)
Nurse-led education and counselling to enhance adherence to phosphate binders
Yoleen P. Van Camp et al.
JOURNAL OF CLINICAL NURSING (2012)
Effects of Phosphate Binders in Moderate CKD
Geoffrey A. Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Comparison of Dietary Phosphate Absorption After Single Doses of Lanthanum Carbonate and Sevelamer Carbonate in Healthy Volunteers: A Balance Study
Patrick Martin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Prescribed Dietary Phosphate Restriction and Survival among Hemodialysis Patients
Katherine E. Lynch et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Prevention and Control of Phosphate Retention/Hyperphosphatemia in CKD-MBD: What Is Normal, When to Start, and How to Treat?
Kevin J. Martin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Pharmacotherapy of chronic kidney disease and mineral bone disorder
Fellype Carvalho Barreto et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Extra-Phosphate Load From Food Additives in Commonly Eaten Foods: A Real and Insidious Danger for Renal Patients
Omar Benini et al.
JOURNAL OF RENAL NUTRITION (2011)
Nutrition and chronic kidney disease
Denis Fouque et al.
KIDNEY INTERNATIONAL (2011)
Pharmacology, efficacy and safety of oral phosphate binders
Alastair J. Hutchison et al.
NATURE REVIEWS NEPHROLOGY (2011)
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice
Nigel D. Toussaint et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Juergen Floege et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia
Thomas Plagemann et al.
HEALTH ECONOMICS REVIEW (2011)
Outcomes Associated With Phosphorus Binders in Men With Non-Dialysis-Dependent CKD
Csaba P. Kovesdy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis
Steven Fishbane et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Association of Dietary Phosphorus Intake and Phosphorus to Protein Ratio with Mortality in Hemodialysis Patients
Nazanin Noori et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease
Thurid Ahlenstiel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.
Marcello Tonelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Thinking Outside the Pillbox - Medication Adherence as a Priority for Health Care Reform
David M. Cutler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dietary Phosphorus Restriction in Advanced Chronic Kidney Disease: Merits, Challenges, and Emerging Strategies
Orlando M. Gutierrez et al.
SEMINARS IN DIALYSIS (2010)
Phosphorus Additives in Food and their Effect in Dialysis Patients
Jaime Uribarri
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Yi-Wen Chiu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Phosphorus Binders and Survival on Hemodialysis
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease
Christina Karamanidou et al.
BMC Nephrology (2009)
ADHERENCE TO PRESCRIBED ORAL MEDICATION IN ADULT PATIENTS UNDERGOING CHRONIC HEMODIALYSIS: A CRITICAL REVIEW OF THE LITERATURE
H. Schmid et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2009)
Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden
Anne M. Murray
ADVANCES IN CHRONIC KIDNEY DISEASE (2008)
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
Christian S. Shinaberger et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: A multicenter study
Rajnish Mehrotra et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
Alastair J. Hutchison et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
Stuart M. Sprague
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
Phosphate metabolism in the setting of chronic kidney disease: Significance and recommendations for treatment
Bryan Kestenbaum
SEMINARS IN DIALYSIS (2007)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
G. A. Block et al.
KIDNEY INTERNATIONAL (2007)
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol - A randomized controlled trial
Jeannie K. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
K. Kalantar-Zadeh et al.
KIDNEY INTERNATIONAL (2006)
A meta-analysis of the association between adherence to drug therapy and mortality
Scot H. Simpson et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
The case against calcium-based phosphate binders
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Improving outcomes for dialysis patients in the international dialysis outcomes and practice patterns study
Friedrich K. Port et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients
ML Unruh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study
Y Slinin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2005)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider
HJ Manley et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
分享论文
